Barclays PLC Boosts Stock Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Barclays PLC lifted its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 109.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,420,356 shares of the real estate investment trust's stock after buying an additional 741,959 shares during the quarter. Barclays PLC owned about 0.60% of Sabra Health Care REIT worth $24,601,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Principal Financial Group Inc. boosted its holdings in shares of Sabra Health Care REIT by 2.5% in the fourth quarter. Principal Financial Group Inc. now owns 22,109,683 shares of the real estate investment trust's stock worth $382,940,000 after acquiring an additional 536,247 shares during the period. JPMorgan Chase & Co. grew its holdings in Sabra Health Care REIT by 4.3% during the 4th quarter. JPMorgan Chase & Co. now owns 10,312,991 shares of the real estate investment trust's stock valued at $178,621,000 after buying an additional 426,074 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Sabra Health Care REIT by 1.4% during the fourth quarter. Geode Capital Management LLC now owns 6,381,525 shares of the real estate investment trust's stock valued at $110,550,000 after buying an additional 86,727 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Sabra Health Care REIT by 13.0% in the fourth quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock worth $69,967,000 after buying an additional 463,601 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of Sabra Health Care REIT by 33.7% in the fourth quarter. Wellington Management Group LLP now owns 3,205,042 shares of the real estate investment trust's stock valued at $55,511,000 after acquiring an additional 808,207 shares during the period. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Stock Down 0.2 %

Shares of SBRA opened at $18.14 on Friday. Sabra Health Care REIT, Inc. has a 1 year low of $13.49 and a 1 year high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The stock has a 50 day simple moving average of $17.02 and a two-hundred day simple moving average of $17.53. The firm has a market cap of $4.32 billion, a P/E ratio of 34.23, a P/E/G ratio of 1.97 and a beta of 0.93.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, meeting the consensus estimate of $0.36. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. On average, analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.62%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT's dividend payout ratio is presently 226.42%.

Analysts Set New Price Targets

SBRA has been the subject of a number of recent analyst reports. Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, January 7th. JMP Securities upgraded Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price target for the company in a research report on Tuesday, January 7th. Finally, Truist Financial raised their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $19.33.

Sabra Health Care REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.